Form D · Hedge Fund

Zakara Biotechnology Fund Ltd.

Camana Bay, E9 · CIK 0002064139

Offering snapshot reported Apr 17, 2026 · SEC filing

Reported sold
$100M
Indefinite offering
Investors reported
1
Form D · investor count
Minimum accepted
$100K
Reported outside-investor minimum
First sale
Apr 7, 2025
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$50M$100MApr 15, 2025: $50,000,000.00Apr 15, 2025Apr 17, 2026: $100,000,000.00Apr 17, 2026

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$50,000,000 → $100,000,000

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 17, 2026Amendment$100,000,000$50,000,000vs Apr 15, 20251SEC filing
Apr 15, 2025Initial$50,000,000No comparison1SEC filing

Offering details

Securities
Equity, Pooled investment fund
Exemptions
06b, 3C, 3C.7
Duration over one year
Yes
Business combination
No
Sales commissions
$0 (estimated)
Finders' fees
$0 (estimated)
Form D file number
021-543717

Source: Form D, filed Apr 17, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Sabera Loughran Director
Ekwutozia Nwabuzor Director
Janet Okogbaa Director
Zakara Biotechnology Fund Gp Llc Executive, Promoter
Zakara Capital Llc Executive, Promoter

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:
C/O Ogier Global (Cayman) Ltd 89 Nexus Way
Camana Bay, E9, KY1-9009